Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Hammes Ranked as Top Developer in 2023 Outpatient Healthcare Real Estate Development Report


News Image

Last year, we led the development of a wide range of outpatient projects, including cancer centers, orthopedic centers, surgery centers, freestanding emergency departments, and multi-specialty outpatient centers and medical office buildings, all of which bring critical care closer to patients.

Hammes has been ranked as the nation’s No. 1 developer in the 2023 Outpatient Healthcare Real Estate Development Report. The annual report, produced by healthcare real estate data firm Revista and Healthcare Real Estate Insights (HREI) magazine, measures development activity based on the total square footage of outpatient projects started or completed in a calendar year.

“Last year, we led the development of a wide range of outpatient projects, including cancer centers, orthopedic centers, surgery centers, freestanding emergency departments, and multi-specialty outpatient centers and medical office buildings, all of which bring critical care closer to patients,” said Todd Kibler, Principal of Hammes Partners. “We are honored that healthcare providers continue to turn to Hammes for these strategic outpatient development projects.”

In 2022, Hammes was responsible for 12 outpatient development projects throughout the country, ranging in size and scale.

About Hammes

Founded in 1991, Hammes is a vertically integrated real estate solutions platform specializing in healthcare real estate strategy and planning, project management, development, investment, and property management. As a testament to our deep healthcare industry experience, Hammes has been recognized as one of the nation’s leading healthcare developers by Modern Healthcare’s Construction & Design Survey for 24 consecutive years—including 19 years as No. 1— and by Revista’s Outpatient Healthcare Real Estate Development Report. Headquartered in Milwaukee, Wisconsin, Hammes provides services through a network of regional offices strategically located across the United States. http://www.hammes.com

Share article on social media or email:

Sober Martial Arts (SMA) Launches First Center in New York City Fusing Medicine and Martial Arts’ Sciences to Battle Addictions, Trauma and Imbalance


“Sober Martial Arts teaches that addictions are forces within the body and mind. People can build the power to balance the addictive forces, while understanding them from a non-judgmental space,” states Sifu Matthew Klein, Founder

Celebrity wellness expert, Kung Fu master and renowned Sober Coach, Sifu (see-fu) Matthew Klein, has teamed with seasoned medical and psychiatric detox experts to launch The Sober Martial Arts (SMA) Wellness and Recovery Center in New York City.

The SMA Center, now open in Manhattan, is a bespoke, luxury treatment program for motivated and discerning clientele, who need to learn a new way to gain authentic power, fight back against addictions, and heal imbalances. The Center adds a new dimension to recovery for addictions and mental imbalances, stretching beyond standard models of body/chemistry and various therapies.

Seeing the body as a series of electrical states, SMA uses martial arts’ positions, intentions, philosophies and movements to create new power in the body, designed to alter internal imbalances that would otherwise be impossible to shift.

Klein has worked with all who want to stabilize and defeat their addictions. Some of his clients also include: NBA players, business leaders, physicians, royalty,

celebrities, athletes and executives with life-threatening dependencies and other imbalances. He states, “Anybody can do SMA. No prior training or level of athleticism is necessary. SMA teaches that addictions are forces within the body and mind. People can build the power to balance the addictive forces, while understanding them from a non-judgmental space.”

SMA’s program has provided successful results for a diverse group of clients. Examples include a global finance tycoon who had nearly drunk himself to death on multiple occasions, who is now “clean” and has improved all health symptoms; and a performing artist with a lifelong pot, booze and cigarette addiction who quit permanently in one week and has never looked back.

“At our center in New York, we are excited to provide new answers and skill sets for those who have hopelessly failed to get clean and those who are clean, yet continue to suffer from challenging personality disorders that hinder the acceleration of their lives and relationships,” said Klein.

Working with Klein, in addition to his certified SMA coaches, are a team of integrated medicine doctors along with Psychiatrist and New York University (NYU) faculty member, Dr Jim Dhrymes. Dhrymes’ field of expertise is addiction medicine, trauma and mental imbalances. He offers traditional and alternative approaches to mental and physical recovery. His methods include comprehensive assessment of symptoms and background, nutrition, exercise, and recommendations for ongoing treatment. Dr. Dhrymes strongly recommends the SMA method for recovery because he believes in the importance of movement, mindfulness and martial arts.

As an addict to alcohol starting at age 9, Klein became sober at 22. Though he was substance-free for decades, it was only through his unique practice of martial arts that he was able to understand and transform the deeply ingrained afflictions of mind, body and emotions.

Klein has 40+ years of martial arts study starting at the age of 4. He is a chi master and Sifu of Wing Chung and achieved black belts in Judo and Jiu Jitsu at the early age of 18. He also teaches Liangong and many healing and regeneration systems and is a certified recovery coach. He has lectured and run wellness clinics globally at the Arts Club and Hale Clinic in London, Soho House and the Carillon hotel in Miami.

Klein teaches that the body is the first key to healing: “We don’t use our bodies properly for healing because we aren’t aware of the joy and power our body can bring,” Klein says. “To the addict or traumatized, the body becomes an object s/he casts away, ignoring its creative wisdom, self-sabotaging toward devastation and destruction. With SMA, the body becomes a sacred ally, to build a communication channel and achieve holistic wellness in all areas.

The SMA Center will offer the following luxury bespoke programs for addiction, recovery and wellness:


  • Dual diagnosis treatment
  • Private mentorships with Sifu Matthew, or a certified SMA coach
  • Mastering all addictions including: mental & emotional states like anxiety, rage, shame, mood disorders, personality disorders, ADHD and more.
  • In or outpatient detox
  • Psychiatric, nutritional & integrative medicine support
  • Aftercare wellness programming for 30 days to 1 year.
  • 24/7 SMA coaching support (never relapse again)
  • SMA alumni events & intensives


SMA now also works with luxury rehab centers to train them in the proprietary SMA method.

As an expert in overcoming addictions and developing the Sober Martial Arts system, Klein is available for interviews and speaking engagements in all matters related to authentic wellness, leadership and overcoming addictions and weaknesses. To learn more about Sifu Matthew Klein and Sober Martial Arts’ offerings, visit sobermartialarts.com.

Share article on social media or email:

Pfizer Chairman and CEO Dr. Albert Bourla to Keynote LABEST at UCLA Luskin Conference Center on May 25, 2023


Dr. Albert Bourla, Chairman and CEO of Pfizer

The biotech ecosystem is a major engine of innovation and growth, and an increasing percentage of research candidates are coming from the biotech sector.

UCLA Technology Development Group (UCLA TDG) announced today that Albert Bourla, Chairman and CEO of Pfizer will be a keynote speaker at the Los Angeles Bioscience Ecosystem Summit ‘23 (LABEST, pronounced L-A Best.). Dr. Bourla joins Daren Tang, United Nations World Intellectual Property Organization Director General (UN WIPO) who will also deliver a keynote address at the event.

“The pandemic heightened our recognition that many of today’s most disruptive global healthcare challenges are too great for any one organization to tackle alone. They require world-class collaboration to fuel game-changing innovation,” said Dr. Bourla. “The biotech ecosystem is a major engine of innovation and growth, and an increasing percentage of research candidates are coming from the biotech sector. At Pfizer, we want to help catalyze this ecosystem to help transform these candidates into medicines and deliver more breakthroughs for more patients more quickly.”

Drawing on his 30 years of experience at Pfizer, Dr. Bourla will discuss the evolution of the research ecosystem in life sciences, the importance of biotech startups and how both academia and large biopharmaceuticals companies can catalyze this ecosystem.

“Biotech is the lifeblood of innovation, and the greater L.A. ecosystem of world-class academic centers, research institutions and bioscience companies is nourishing exciting growth. I am proud to be part of this collaborative network and thrilled by the growing interest LABEST now commands from leaders throughout the biopharma world,” said Arie Belldegrun, Roy and Carol Doumani Chair in Urologic Oncology, UCLA.

For the 5th year Dr. Belldegrun will moderate one of the summit’s most highly anticipated panels: Meet the Leaders in the Business of Life Science. Executives on the prestigious panel include

  • Norbert Bischofberger, President & CEO, Kronos Bio
  • David Chang, President, CEO, and Co-Founder, Allogene
  • Mark Cobbold, MD, PhD, VP Discovery Oncology, Head of Oncology Cell Therapy, AstraZeneca
  • Aamir Malik, Chief Business Innovation Officer, Executive Vice President, Pfizer
  • Dennis J. Slamon, MD, PhD, Director of Clinical/Translational Research, and Revlon/UCLA Women’s Cancer Research Program, Jonsson Comprehensive Cancer Center

LABEST is the premier showcase for bioscience innovation in Southern California. With national and international presenters and attendees and a true collaboration with colleagues from across LA county, LABEST presents promising academic research, entrepreneurial faculty investigators, and local startup companies. The goal is to highlight the vibrant startup ecosystem and to facilitate partnerships between academia, the biopharma industry, entrepreneurs and investors.

UCLA TDG is excited to fill the UCLA Meyer and Renee Luskin Conference Center once again for the 2023 event, which will be held on May 25. Throughout the summit, faculty members present the latest scientific breakthroughs, which may lead to the critical therapies of tomorrow. Leading bioscience translational research programs and startups will be showcased where Southern California Institutions have significant expertise, pioneering research and resource commitments to develop innovative patient therapies.

LABEST INFORMATION #LABEST2023 @UCLATDG

DATE: May 25, 2023

TIME: 8:30am – 7:00pm PT

LABEST OFFICIAL WEBPAGE: https://tdg.ucla.edu/news-events/events/labest-2023

LINK TO 2023 PROMOTIONAL VIDEO: https://www.youtube.com/watch?v=6UbfHQhUePY

REGISTRATION:

https://web.cvent.com/event/f3b8fb91-0d21-4987-8840-cb9899ed0153/regProcessStep1

WHERE: UCLA Meyer and Renee Luskin Conference Center

AGENDA: https://tdg.ucla.edu/sites/default/files/2023-04/LABEST%202023%20Agenda%20v13.pdf

SCHEDULE:

https://tdg.ucla.edu/sites/default/files/2023-04/LABEST%202023%20Schedule%20At-A-Glance%20v02.pdf

KEYNOTE SPEAKERS

  • Dr. Albert Bourla – Chairman and Chief Executive Officer, Pfizer
  • Daren Tang – United Nations World Intellectual Property Organization Director General (UN WIPO)


CONFERENCE HIGHLIGHTS

  • In-person conference taking place at the UCLA Meyer and Renee Luskin Conference Center
  • Fireside chat with UC Regents and UCLA Chancellor
  • 12 Interactive Showcases
  • Los Angeles Startup Ecosystem Showcase, Co-Hosted by the Larta Institute and the Lundquist Institute


LABEST SHORT TALK/PANEL DESCRIPTIONS

  • Panel – LA Hospital Leaders Innovating For Future Success: Moderator Judy Fortin, Chief of Communications for UCLA Health. A panel discussion with Hospital CEOs from our long-standing LABEST partners in the Los Angeles area, covering challenges, accomplishments, and what the future has in store for Hospitals.
  • Showcase – “Accelerating Innovation in Oncology”: Led by Edward B. Garon, MD, MS, Thoracic Medical Oncology.    


UCLA Technology Development Group (TDG) serves as a campus-wide gateway to UCLA innovation, research and entrepreneurship. Our mission is to: -Promote UCLA innovation, research, teaching and entrepreneurship to benefit society -Create economic value to support UCLA’s scholarly and educational missions and the State of California -Lead UCLA’s research community to bring innovation to market

Website: http://tdg.ucla.edu

Thank you to our Innovator Sponsors:

Amgen

Kite, A Gilead Company

Share article on social media or email:

Highmark Health, Allegheny Health Network Celebrate 10th Anniversary Milestone


The foundation and infrastructure we have built at AHN is not only greatly improving the experience of people today, but it will continue to do so for many years to come.

Allegheny Health Network (AHN) and its parent company, Pittsburgh-based Highmark Health, this week are celebrating the 10th anniversary of an historic affiliation that radically altered the Western Pennsylvania health care landscape and created a new national model for the successful integration of a health insurer and hospital system. The affiliation also preserved thousands of local health care jobs and ensured that the hospitals and clinical programs of AHN’s predecessor organization, West Penn Allegheny Health System (WPAHS), would continue to thrive as some of the region’s leading sources of high-quality health services.  

“A decade ago, we promised to do something bold and different – we would transform our industry and build a better, more affordable health care model by uniquely blending the payer and provider experience and creating innovative solutions that enable our patients and members to live their best lives,” said David Holmberg, Highmark Health president and CEO. “We are extremely proud of what our exceptional caregivers and team members at every level have accomplished in the pursuit of that goal, and we are even more excited about the future and everything we will do in the days ahead to continue our momentum and further reinvent health care.”

In 2011, WPAHS and its hospitals (Allegheny General, West Penn, Canonsburg, Allegheny Valley, and Forbes) were struggling financially when Highmark – then primarily in the health insurance business – proposed a strategic affiliation between the two organizations.

After nearly two years of negotiation and regulatory review, the merger was approved by the Pennsylvania Insurance Department on April 29, 2013. Highmark Health would be the new name of the parent company, while its new provider organization would be known as Allegheny Health Network.

That same year, two additional local hospital systems were brought into the fold to become part of AHN. On March 1, 2013, just weeks before the official creation of AHN, the hospital formerly known as Jefferson Regional Medical Center (now AHN Jefferson Hospital, based in Jefferson Hills, Pa.) joined Highmark’s then-unnamed health care delivery system. And on July 9, 2013, Saint Vincent Health System in Erie, Pa., also joined the organization.

Since then, the network has grown dramatically, building six new large-scale multispecialty outpatient facilities (called Health + Wellness Pavilions), four new smaller-scale “neighborhood hospitals,” one full-service 160-bed hospital in Wexford, Pa., and six new cancer centers located throughout Western Pennsylvania, including a new Cancer Institute hub on the campus of Allegheny General Hospital.

In the last decade, AHN has also opened two new obstetrical units, one at Jefferson Hospital in 2014, and one at the new AHN Wexford Hospital, which opened in 2021, and has completed major expansions of the emergency departments at AHN Saint Vincent and Jefferson, among many other investments.

Much of AHN’s expansion was fueled by a billion-dollar, multi-year strategic investment campaign, which was announced by AHN and Highmark Health in October 2017: “We are listening to our patients and members and developing 21st-century care models, programs and facilities that place their health care needs and preferences at the center of everything we do,” Holmberg said at the time.

In 2020, AHN also finalized an affiliation agreement with Grove City Medical Center, bringing the network’s hospital count to 14. In total, AHN now operates more than 300 sites of care, and the network is staffed by more than 22,000 employees and approximately 2,600 credentialed physicians. It annually sees about 3.6 million patients in its physician practices, manages more than 1.7 million outpatient visits, treats more than 330,000 patients in its emergency departments, performs more than 100,000 surgical procedures, and delivers about 8,600 babies. 

“Thanks to the significant investments that Highmark Health has made in AHN over the past 10 years, our communities today have better access to high quality health care and they are stronger economically because of our impact on jobs creation, the purchase of goods and services, and our community giving, ” said James Benedict, AHN president. “We are also advancing the frontier of health care though innovative medical research and robust academic programs that train the next generation of caregivers.  So the foundation and infrastructure we have built at AHN is not only greatly improving the experience of people today, but it will continue to do so for many years to come.”  

Starting in 2020, the organization led the region’s response to the COVID-19 pandemic, a multi-faceted effort that culminated with a series of mass-vaccination clinics that took place at PNC Park, Erie Insurance Arena, DSG corporate headquarters, and many other large venues throughout 2021. In total, more than 500,000 vaccines were delivered in western Pennsylvania by AHN caregivers, and AHN hospitals cared for more than 44,000 COVID patients.

“Our organization’s response to the pandemic required an enormous, unprecedented mobilization of leadership and resources that demonstrated the true value of the AHN-Highmark Health partnership in a very tangible way,” Benedict said. “For instance, Highmark could not have organized such large-scale vaccination events without AHN’s clinical and operational expertise. And AHN couldn’t have done it without Highmark Health’s organizational support and community relationships. But together, we were able to do remarkable, life-saving work, during one of the most challenging public health emergencies of our lifetimes.”

While the first several years of affiliation were spent growing AHN’s clinical footprint and fortifying its operational foundation, the last few years have been dedicated to strengthening the partnership between AHN and Highmark Health, honing the “Living Health” model that seeks to transform health care by leveraging data insights and clinical expertise to deliver better health outcomes, better patient and caregiver experiences, and more equitable access to resources – all while lowering the overall costs of care.

Though Highmark Health and AHN are celebrating the 10th anniversary of their affiliation, both have much longer legacies of community service.  Highmark Inc., which offers Blues-branded health insurance plans in four states, was formed through the merger of Blue Cross of Western Pennsylvania and Pennsylvania Blue Shield, both of which date to the 1930s. And while AHN was the successor to WPAHS – which itself was created in 1999 – many of its member hospitals are more than a century old. The oldest is Bloomfield’s West Penn Hospital, which was chartered on March 18, 1848, and recently celebrated its 175th anniversary.

“There were doubters, especially early on, that an insurer and a health care provider could make it work,” said Donald Whiting, MD, AHN Chief Medical Officer and AHN’s Neurosciences Institute Chair, who has been part of the AHN and WPAHS family for more than two decades. “But this relationship has proven to be an extraordinary success, and one that has allowed AHN to grow and flourish, expanding its leading-edge clinical programs and introducing new, world-class health care resources to so many of the communities we serve.”

NanoFCM Partners with RoosterBio as an Approved Service Provider for Exosome Analysis


“The in-depth knowledge and expertise in EV characterization provided by RoosterBio will allow new and existing EV platforms to thrive in this exciting field.” – Ben Peacock, Head of Research, NanoFCM Co., Ltd.

NanoFCM Co., Ltd today announced that RoosterBio, Inc. a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, development services, cell engineering, and advanced therapy bioprocess solutions, is approved to provide analytical services worldwide using NanoFCM’s NanoAnalyzer.

In this strategic partnership, RoosterBio becomes the first US-based service provider approved by NanoFCM to perform contract analytical services using the NanoAnalyzer platform. RoosterBio has leveraged the NanoAnalyzer in its exosome / extracellular vesicle (EV) analytics workflows for over a year and offers this technology as a stand-alone service as well as integrated within broader exosome process development programs.

In recent years, exosomes have emerged as a powerful new therapeutic modality, and the number of EV-based products in preclinical and clinical development is increasing rapidly. Traditional methods for exosome characterization have been limited to population-level analysis, while conventional flow cytometry lacks the sensitivity required for single nanoparticle analysis. NanoFCM’s NanoAnalyzer instrument has become established as a powerful tool for multiparameter characterization of natural and synthetic nanoparticles at the single-particle level. RoosterBio is routinely applying this technology to accelerate its customers’ path to the clinic as part of a comprehensive suite of analytical methods to characterize the quality, identity, purity, and potency of both native and genetically engineered exosome products.

RoosterBio and NanoFCM will leverage their combined expertise to develop updated protocols, procedures, and expanded analytical capabilities for NanoFCM’s NanoAnalyzer instrument.

“The in-depth knowledge and expertise in EV characterization provided by RoosterBio will allow new and existing EV platforms to thrive in this exciting field” said Ben Peacock, Head of Research for NanoFCM Co., Ltd. “Coupled with innovative technologies like NanoFCM’s NanoAnalyzer these analytical services will drive promising advancement in EV research, therapeutics and prognostics.”

“We are delighted to be selected as an approved provider for state-of-the-art exosome analytical characterization using NanoFCM’s NanoAnalyzer technology,” said Tim Kelly, Chief Executive Officer of RoosterBio. “Exosomes offer extremely high utility as a new therapeutic modality with the potential to address unmet medical needs, but perhaps the biggest obstacle the field faces is the lack of sensitive, quantitative technologies for EV characterization. Together with NanoFCM, we are solving these key challenges and creating the framework for a truly well-characterized EV biologic.”

About RoosterBio

RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and extracellular vesicle (EV) product and process development to fuel the rapid implementation of scalable advanced therapies. Our high-quality hMSCs, bioprocess media, genetic engineering tools, and EV production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity. With optimized, scalable processes, Type 2 Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under 1 year. RoosterBio is driven by client’s success and creating a world where safe and effective regenerative medicines are rapidly developed and widely available on a global scale.

About NanoFCM

Implementing strategies for single particle quantification and cargo detection, NanoFCM provides a versatile and powerful platform with the NanoAnalyzer, a flow cytometry based system for multi-parameter nanoparticle analyses. Precise measurement of elastically scattered light from single nanoparticles allows for high-resolution size distribution, comparable to cryo-electron microscopy, with fast acquisition times of 1-2 minutes also yielding particle concentration data. Fluorescent labelling technologies can be implemented to yield concurrent detection of important cargos such as proteins, nucleic acids and lipids. Global implementation at some of the top research institutions and high-tech enterprises continue to demonstrate the benefits of nano-flow cytometry for particle characterization.

Share article on social media or email:

AHN Schools of Nursing Now Accepting Applications for Class of 2025


AHN Schools of Nursing offer 22-month registered nurse (RN) programs, with classroom learning and hands-on clinical experiences led by highly qualified faculty members.

One of the many benefits of attending AHN’s nursing schools is the opportunity to be hired within the network post-graduation, with a highly competitive salary when hired.

Allegheny Health Network’s (AHN) Schools of Nursing are seeking applicants to join the next generation of standout nurses.

Applications are being accepted through June 15 for AHN’s two nursing schools: West Penn Hospital School of Nursing in Pittsburgh’s Bloomfield neighborhood, and Citizens School of Nursing in Tarentum.

Both schools offer 22-month registered nurse (RN) programs, with classroom learning and hands-on clinical experiences led by highly qualified faculty members. Small class sizes and one-on-one learning opportunities provide a personalized experience for each student.

The schools’ diploma programs are completed in half the time of a four-year collegiate program. Nursing school tuition is also significantly more affordable than a college-based bachelor’s program.

“AHN’s Schools of Nursing set students up for success from the very beginning,” said Amy Stoker, PhD, RN, director of the West Penn School of Nursing. “Our engaged and caring instructors prioritize relationship-building with each student to ensure they feel comfortable and confident as they pursue their nursing careers.”

Over 90% of graduates who seek employment as entry-level registered nurses will obtain a position in a health care setting within one year of graduation.

“One of the many benefits of attending AHN’s nursing schools is the opportunity to be hired within the network post-graduation, with a highly competitive salary when hired,” said Ruth Tarantine, DNP, director of AHN Schools of Nursing and the Citizens School of Nursing. “The familiarity from clinical experience makes the transition seamless for students who choose to stay in the network to pursue their nursing careers.”

Jacob Tirk, 21, of South Butler, is one of the 25 nurses graduating from the Citizens School of Nursing on May 3, and already has a job secured at AHN’s Allegheny General Hospital (AGH), working in the Cardiothoracic Telemetry unit. He credits his instructors at the Citizens School of Nursing for his remarkable nursing school experience.

“Before attending the Citizens School of Nursing, I heard about how engaging and accessible the instructors were, and I found that to be true during my time there,” shared Tirk. “Their ongoing support was vital to my success and helped prepare me to excel throughout my education. I’m looking forward to applying what I learned to my new career at AGH this spring.”

Daniela O’Neil, 26, is originally from West Palm Beach, Florida, and pursued nursing as her second career. She moved to Pittsburgh to attend the West Penn School of Nursing after living in New York City at the beginning of the COVID-19 pandemic. She’s one of the 40 nurses graduating from the West Penn School of Nursing on May 25.

O’Neil will remain in Pittsburgh after graduation and begin her new job as a NICU nurse at West Penn Hospital.

“Nursing school is challenging, but the support provided by the instructors at West Penn School of Nursing allows anyone who wants to become a nurse to succeed in their career,” shared O’Neil.

AHN Schools of Nursing offers types of financial aid such as federal government grants, federal student loans, state grants, scholarships, and private educational loans. On-site housing is available at the West Penn School of Nursing, while the Citizens School of Nursing has free, on-site parking.

AHN is one of just a handful of hospital systems to operate multiple nursing schools. Since the 1970s, as college nursing programs proliferated nationally, hospital-affiliated diploma programs began to close. But the Northeast, and Pennsylvania in particular, maintain a strong tradition of hospital-based education for nurses.

To learn more about the AHN Schools of Nursing, visit https://www.ahn.org/health-care-professionals/education/nursing/schools.

Share article on social media or email:

Chicago Red Stars Team Up with Official Fertility Partner, Fertility Centers of Illinois, for National Infertility Awareness Week (NIAW)


Chicago Red Stars Team Up with Official Fertility Partner,
Fertility Centers of Illinois, for NIAW

With FCI as our Official Fertility Partner, we hope to open up important conversations surrounding infertility and fertility preservation so that more people can receive the fertility care needed to grow their families.

The Chicago Red Stars (CRS) and their Official Fertility Partner, Fertility Centers of Illinois (FCI), are working together to shed light on the one in eight people affected by infertility and the family-building options and free support available to them during National Infertility Awareness Week (NIAW), April 23 to 29.

NIAW is a yearly initiative founded by RESOLVE: The National Infertility Association, of whom FCI has been a longtime supporter, to encourage a widespread conversation about infertility and educate others on the impact of infertility within their community. Whether it be on the soccer field or building a family through fertility treatment, CRS and FCI empower their communities to support one another and share their stories.

In honor of NIAW, CRS defender, Arin Wright, sat down for the let’s talk fertility interview series with FCI physician, Channing Burks Chatmon, M.D., to raise fertility awareness and remove the stigma around infertility.

“Fertility is that word that no one really wants to talk about because it’s associated with infertility. I think that narrative needs to change and we need to take our fertility into our own hands,” shares Wright. “With FCI as our Official Fertility Partner, we hope to open up important conversations surrounding infertility and fertility preservation so that more people can receive the fertility care needed to grow their families.”

CRS also advocates for fans to learn more about infertility through the many resources offered by FCI, including an extensive resource library, free virtual fertility events, and a thriving social media community.

As the Official Fertility Partner of the Chicago Red Stars, FCI promotes fertility awareness by providing players and staff with fertility education as well as fertility preservation and other family-building benefits.

“We’re so proud to be partners with the Chicago Red Stars, as they shine a light on family-building and fertility preservation for anyone who might be facing barriers to growing the family of their dreams — a testament to these players’ own courage and leadership on the issue of fertility awareness in our community,” shares Christopher Sipe, M.D., Medical Director of FCI.

For people facing barriers to building their families, it may be time to consult a fertility specialist. Contact the FCI New Patient Center at 1-877-324-4483 to schedule a fertility consult with an FCI physician.

About the Chicago Red Stars

Established in 2007, the Red Stars were a founding member of the former Women’s Professional Soccer and would later become one of the original eight teams to form the National Women’s Soccer League in 2013. The Red Stars have made the playoffs in seven consecutive years from 2015-2021, appearing in the NWSL Championship in 2019 and 2021 as well as appearing in the NWSL’s Challenge Cup Final in 2020.

About Fertility Centers of Illinois

Fertility Centers of Illinois (FCI) is one of the leading fertility treatment practices in the United States, providing advanced reproductive endocrinology services for over 35 years with more than 42,000 babies born. With a 13-physician team of nationally and internationally recognized doctors who treat thousands of patients each year, the practice has earned a reputation for medical and clinical excellence and continues to invest in the latest state-of-the-art technologies and research. FCI offers a comprehensive range of fertility treatments with an emphasis on in vitro fertilization, third-party reproduction, egg donation, gestational carriers, genetic embryo screening, and egg freezing/oocyte vitrification, allowing patients to receive all of their care at one center. As the premier and largest fertility practice in the Midwest region, Fertility Centers of Illinois serves patients in the Chicagoland region, northern Indiana, and southern Wisconsin. Patients receive individualized care with accommodating financial options and a free patient support program. Learn more by calling 877-324-4483 or visiting fcionline.com

Share article on social media or email:

Sacred Essentials™ Announces its Strongest Pain Balm Formula in Response to Growing Customer Demand for Natural Relief


“I am inspired by our customers, who have told us the reason they’re using our CBD products is to help address pain, stress, and inflammation in the body,” says Silvia Orizaba, founder of Sacred Essentials.

Sacred Essentials™ has been making waves in the CBD industry with high-quality, full spectrum products designed to enhance wellness and help with pain symptoms. Recently, the trusted brand launched a new maximum-strength CBD pain balm after growing customer demand for even stronger versions of its Signature CBD Infused Pain Balm, adding to its premier CBD portfolio.

The expanded collection, with the mission to address a need for natural relief for persistent aches and pains, includes the Maximum Strength CBD Infused Pain Balm, designed with three times the CBD of the original formula, for everyday relief from joint and muscle pain. In addition, the company is now offering its popular Extra Strength CBD Infused Pain Balm in an extra value size, offering three times the product of the regular size but at only twice the price.

“I am inspired by our customers, who have told us the reason they’re using our CBD products is to help address pain, stress, and inflammation in the body. This feedback is vital when creating new products so we can tailor to our customers’ needs, and create more potent formulations that continue to help ease discomfort,” says Silvia Orizaba, founder of Sacred Essentials. “Our signature product, the CBD Infused Pain Balm, was crafted to help deliver natural, fast, and effective pain relief, so we decided to kick it up a notch and create two additional balms that offer even more of our pain fighting ingredients.”

Each product is formulated without dyes nor added fragrances, and starts with an antioxidant olive oil base blended with fast-acting menthol and essential oils, chamomile, lavender, and vitamin E. Then, products are infused with full spectrum CBD oil extracted from US-grown hemp using a clean CO2 process tested for purity by a third party.

The effective formulas, crafted by Orizaba alongside scientists, chemists, and farmers, combine a unique blend of naturally derived ingredients, full-spectrum CBD oil, and proven pain relieving ingredients that benefit the human body and mind.​​ The CBD portfolio also includes tinctures for nighttime rest and wellness and edible gummies and mints for relaxation and relief.

For more information on these new offerings, please visit http://www.getsacred.com, where the full line of products is available.

Share article on social media or email:

MYOS CORP Announces Launch of Equine Muscle Formula on Heels of Successful Clinical Trial on Palatability of Fortetropin® with Horses


“MYOS recognizes the importance of the equine market and the significant potential benefits of Fortetropin,” said MYOS CORP CEO Joe Mannello. “We believe a safe, all-natural muscle building product for horses has the potential to revolutionize the industry.”

MYOS CORP, a research-based, advanced nutrition company, today announced the positive results of a study to determine the palability of its proprietary muscle health ingredient, Fortetropin®, with horses. With this positive study in hand, MYOS is planning an entrance into the lucrative equine industry with a May 2023 launch of a new product, MYOS Equine Muscle Formula®.

The equine palability study took place over two weeks at the Petaluma Equine Center in Petaluma, CA. The study consisted of 15 horses separated into three groups. Each group was fed daily either a placebo (cheese powder), 24g of Fortetropin, or 48g of Fortetropin. Serum chemistry, hematology, and fibrinogen, as well as physical exams and body weight were measured prior to the study; on the first day of administration and at the conclusion of the study. Physical exams were unchanged throughout the study. No clinically significant changes were observed in serum chemistry, hematology, and fibrinogen pre & post administration of Fortetropin.

“No adverse events were observed in any of the horses in all three groups receiving placebo or the sweetened formulation of Fortetropin,” said the lead investigator Dr. Daizie Labelle, DVM, MBA, CCRP. “Horses readily ate this formulation top dressed on moistened stable mix pellets. Our data suggest that horses tolerate Fortetropin at doses of 72-109mg/kg.”

Research on the muscle health efficacy of Fortetropin has been conducted with humans, canines, and felines. The product has been clinically shown to increase the rate of muscle protein synthesis, increase lean muscle mass, and reduce muscle atrophy.

For horses, muscle atrophy is a serious problem that can arise from conditions such as Cushing’s disease, disuse atrophy, injury, malnutrition, and various genetic or immune-mediated myopathies. To be able to provide a safe, all-natural dietary supplement that can counteract the effects of atrophy can be a significant step forward in equine health.

Despite the lack of an equine-specific offering from MYOS until now, several prominent horse trainers have been giving their animals Fortetropin for years.

“There are other products in the equine market that address muscle, but none of them work as good as this!” said leading equine sports veterinarian Geoff Vernon, DVM.

According to a report by ResearchAndMarkets.com, the global equine industry was valued at $300 billion in 2020, and it is projected to reach $405 billion by 2026, growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period. In the United States alone, the equine industry contributes approximately $122 billion to the economy annually. According to the American Horse Council Foundation’s National Economic Impact Study, there are approximately 7.2 million horses in the United States. Other countries with large equine industries include China, Japan, Germany, France, and the United Kingdom.

“MYOS recognizes the importance of the equine market and the significant potential benefits of Fortetropin,” said MYOS CORP CEO Joe Mannello. “With eight clinical studies supporting Fortetropin’s ability to increase lean muscle mass and speed up recovery, this presents an excellent opportunity to expand our presence in this market. Prior to entering the equine market, we received positive feedback from Equine Vets who had success using Fortetropin. We believe a safe, all-natural muscle building product for horses has the potential to revolutionize the industry.”

The equine industry encompasses a wide range of activities, including horse racing, breeding, training, showing, recreational riding, and therapeutic riding. It also includes a variety of supporting industries, such as feed and equipment manufacturers, veterinarians, and transportation providers.

About MYOS CORP.

MYOS CORP is a Cedar Knolls, NJ-based medical nutrition company that develops products that improve muscle health in people and animals. MYOS is the owner of Fortetropin®, a fertilized egg yolk-based product manufactured via a proprietary process to retain and optimize its biological activity. Fortetropin has been clinically shown to increase muscle size, lean body mass, and reduce muscle atrophy. MYOS products include MYOS Canine Muscle Formula® (Original & Vet Formula), MYOS Feline Muscle Formula®, and YOLKED®. For more information, please visit http://www.myospet.com. If you have any questions please contact mailto:info@myospet.com [info@myospet.com __title__ null].

Share article on social media or email:

Young Living Appoints Steve Carlile as New Chief Marketing and Digital Officer


Steve Carlile

We are thrilled to welcome Steve to the Young Living family. Steve’s deep expertise connecting audiences on an international scale means he’s intrinsically aligned with our community of dreamers, achievers, and go-getters that dot the globe.

Young Living Essential Oils, a leader in the essential oils industry, is pleased to announce the appointment of Steve Carlile as the company’s new Chief Marketing and Digital Officer.

“We are thrilled to welcome Steve to the Young Living family,” said Ben Riley, President. “Steve’s deep expertise connecting audiences on an international scale means he’s intrinsically aligned with our community of dreamers, achievers, and go-getters that dot the globe. He also has an innate ability to anticipate industry trends, which makes Steve a perfect match for the Young Living brand.”

Carlile comes to Young Living with more than 20-years of experience. He is an expert in connecting a brand’s purpose with its audience using innovative strategies and customer experience roadmaps. Carlile was previously featured in Deloitte Insight’s Global Marketing Trends Report and selected to participate in their Next Generation CMO Academy, alongside noted luminaries in the marketing world.

Before joining Young Living, Carlile served as Chief Marketing and Digital Officer at Younique. He led the development and launch of the company’s most successful product in its history. Carlile’s holistic leadership style and focus on establishing meaningful connections with employees is directly aligned with Young Living’s continued efforts to foster wellness, purpose, and abundance as part of its brand.

“I am thrilled to accept this role with Young Living. This company’s ability to maintain relevance with consumers in such a competitive landscape sets it apart from other brands in the space. I look forward to working with the team to continue ensuring Young Living’s industry leadership in delivering the highest quality products.”

Carlile is also highly committed to his community by serving on various local business boards and educating young people through involvement in the Future Business Leaders of America program.

About Young Living Essential Oils

Young Living Essential Oils, LC, based in Lehi, Utah, is the world leader in essential oils, offering the highest-quality oil-infused products available. Young Living takes its industry leadership seriously, setting the standard with its proprietary Seed to Seal® quality commitment. This guiding principle helps Young Living protect the planet and provide authentic products that its Brand Partners and Customers can feel confident using and sharing with friends and family. Young Living’s products—sourced from corporate-owned farms, partner farms, and other trusted suppliers—not only support a healthy lifestyle, but also provide opportunities for over 6 million global Brand Partners to find a sense of purpose and whole-life wellness by aligning their work with the Young Living values and passions. For more information, visit YoungLiving.com, follow @youngliving on Instagram or like us on  Facebook.

Share article on social media or email: